Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nasdaq  >  Galena Biopharma Inc    

 SummaryChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Financials ($)
Sales 2016 -
EBIT 2016 -31,6 M
Net income 2016 -22,5 M
Debt 2016 -
Yield 2016 -
Sales 2017 -
EBIT 2017 -5,77 M
Net income 2017 -29,7 M
Debt 2017 -
Yield 2017 -
P/E ratio 2016 -
P/E ratio 2017
Capi. / Sales2016 0
Capi. / Sales2017 0
Capitalization 20,7 M
More Financials
Company
Galena Biopharma, Inc. is a biopharmaceutical company committed to the development and commercialization of hematology and oncology therapeutics that address unmet medical needs.The company focuses on identifying and advancing therapeutic opportunities to improve cancer care from direct treatment... 
Sector
Pharmaceuticals
Calendar
03/29Earnings Release
More about the company
Surperformance© ratings of Galena Biopharma Inc
Trading Rating : Investor Rating : -
More Ratings
Latest news on GALENA BIOPHARMA INC
01:33p GALENA BIOPHARMA : The Law Offices of Howard G. Smith Announces the Filing of a ..
05:44a Law Offices of Howard G. Smith Commences Investigation on Behalf of Galena Bi..
02/23 GALENA BIOPHARMA INC : Lundin Law PC Announces Securities Class Action Lawsuit a..
02/23 GALENA BIOPHARMA INC : Bronstein, Gewirtz & Grossman, LLC Notifies Investors of ..
02/23 Khang & Khang LLP Announces Securities Class Action Lawsuit against Galena Bi..
02/22 GALENA BIOPHARMA : Board of Directors Appoints Stephen F.Ghiglieri as Interim Ch..
02/22 GALENA BIOPHARMA INC : Stephen F. Ghiglieri Has Been Appointed Interim CEO
02/21 GALENA BIOPHARMA, INC. (NASDAQ : GALE) Files An 8-K Departure of Directors or Ce..
02/21 GALENA BIOPHARMA, INC. : Change in Directors or Principal Officers, Financial St..
02/21 Galena Biopharma Board of Directors Appoints Stephen F. Ghiglieri as Interim ..
More news
Sector news : Pharmaceuticals - NEC
04:12pDJASTRAZENECA : Hyperkalaemia Drug Clears Scientific Hurdle for European Approval
02:02pDJASTRAZENECA : Gets Approval for Drug Treating Hyperkalaemia
12:59a Exclusive - Trump says Republican border tax could boost U.S. jobs
02/23DJPFIZER : Files 8K - Changes Executive Management
02/23DJGlaxoSmithKline Reports Positive Study Results for Asthma Drug
More sector news : Pharmaceuticals - NEC
Latest Tweets
02/21BRIEF-Galena Biopharma board appoints Stephen Ghiglieri as interim CEO  
02/21Galena Biopharma Board of Directors Appoints Stephen F. Ghiglieri as Interim .. 
02/17BRIEF-CVI Investments reports 9.3 pct passive stake in Galena Biopharma  
02/16Glancy Prongay & Murray LLP : Files Securities Class Action Lawsuit Again.. 
02/15Robbins Arroyo LLP: Galena Biopharma, Inc. (GALE) Misled Shareholders Accordi.. 
More tweets
Qtime:21
News from SeekingAlpha
2016 Galena Biopharma's (GALE) CEO Mark Schwartz on Q3 2016 Results - Earnings Cal..
2016 Galena Biopharma beats by $0.02
2016 Notable earnings after Wednesday?s close
2016 RXI PHARMACEUTICALS : Moving On Promising Scar Treatment
2016 Best And Worst Performing Stocks Of 2016
Advertisement
Chart GALENA BIOPHARMA INC
Duration : Period :
Galena Biopharma Inc Technical Analysis Chart | US3632561086 | 4-Traders
Full-screen chart
Technical analysis trends GALENA BIOPHARMA INC
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Technical analysis
Income Statement Evolution
More Financials
Consensus 
Mean consensus HOLD
Number of Analysts 4
Average target price 6,00 $
Spread / Average Target 831%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Sanford J. Hillsberg Chairman
Stephen F. Ghiglieri Chief Financial Officer & Executive Vice President
Bijan Nejadnik Chief Medical Officer & Executive Vice President
Stephen S. Galliker Independent Director
Rudolph Nisi Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
GALENA BIOPHARMA INC-87.52%21
JOHNSON & JOHNSON3.74%331 089
ROCHE HOLDING LTD.5.98%209 906
PFIZER INC.3.42%206 688
NOVARTIS AG3.51%201 806
MERCK & CO., INC.10.91%181 558
More Results